2016 Fiscal Year Final Research Report
Development new immunotherapy for pediatric cancer using human iPSCs
| Project/Area Number |
26461583
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | iPS細胞 / ガン免疫療法 |
|---|
| Outline of Final Research Achievements |
We aimed to develop more efficient immunotherapy for pediatric cancer, using WT1 cancer vaccines and human iPSCs. We established the method to generate iPSCs more efficiently using Sendai virus.In addition, we developed oral cancer vaccine method using Bifidobacterium longum displaying WT1 protein.
|
| Free Research Field |
小児血液学
|
